Meeting summary - Medicine shortages (SPOC) working party 10-11 April 2025
Meeting summary - Medicine shortages (SPOC) working party 10-11 April 2025
Meeting summary - Medicine shortages (SPOC) working party 10-11 April 2025
Applicant / marketing authorisation holder change of contact person for product invented name / product number template
List of medicines currently in PRIME scheme
Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 19-22 May 2025
Draft guideline on good pharmacovigilance practices (GVP): Module XVI Addendum I – Educational materials
Veterinary medicines European public assessment report (EPAR): Hepizovac, epizootic haemorrhagic disease vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prazivetin, praziquantel, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prevestrus vet, finrozole, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+EDS, infectious bronchitis,Newcastle disease,egg drop syndrome virus vaccine (inactivated), Status: Authorised
Human medicines European public assessment report (EPAR): Temozolomide Accord, temozolomide, Date of authorisation: 15/03/2010, Revision: 25, Status: Authorised